The Effective Statistician - in association with PSI
Alexander Schacht and Benjamin Piske, biometricians, statisticians and leaders in the pharma industry
0
This podcast, produced in association with PSI (Promoting Statistical Insight), is designed for statisticians to enhance their impact at work. It focuses on leadership skills, scientific community discussions, knowledge of the health sector, and work efficiency. Aimed at statisticians at all levels, it also touches on topics relevant to the broader data science community.
Episodes
-
Similar Teams, Different Outcomes — Why? 16.11.2026 28mWhy do teams with similar expertise achieve very different results? I with coach and trainer Christina Sohn about how shared goals, trust, and constructive conflict shape team performance. They discuss practical ways to speak up, handle disagreements, and build stronger connections in virtual teams. -
Move Beyond Excel with R for Health Technology Assessment 02.11.2026 26mWhen should we move beyond Excel for health technology assessment? I sit down with Dr Robert Smith to explore why increasingly complex health economic models call for a different approach—and how R can help. We discuss the challenges of reviewing large spreadsheets, R’s strengths for simulation modelling, and how the R for HTA community shares tools and knowledge. Robert also explains how generative AI speeds up coding while making domain expertise, clear problem definition, and human judgement even more valuable. We close with practical ways to learn, contribute, and get involved in open-sour... -
Turn Data into Decisions by Putting People First 26.10.2026 23mHow can we make sure our analyses lead to action? I’m joined by Dr. Annika Bergbauer, economist, IT management consultant, and host of Datenaffaire, to explore how we can put people at the centre of data-driven decisions. We discuss stakeholder engagement, clear communication, and the human skills that help us turn technical work into practical impact. -
Better Dose Decisions and a Culture of Statistical Innovation 19.10.2026 38mHow can statisticians improve dose decisions and drive innovation in their everyday work? I speak with Marie-Karelle Rivière and Anaïs Andrillon from Saryga about Project Optimus, their approach to dose optimization, and what it takes to turn challenging questions into meaningful research. -
Five Lessons for a Meaningful Career in Statistics 12.10.2026 41mWhat helps us build a fulfilling career in statistics beyond technical expertise? In this episode, I speak with Godwin Yung, who leads the Statistical Methodology group at Roche–Genentech, about lessons from his first decade in the pharmaceutical industry. We explore three themes from his career reflections: finding purpose, listening to understand, and learning from mentors. Godwin shares the personal stories behind these lessons, from persevering through a difficult publication journey to discovering leadership strengths he once took for granted. Together, we discuss how we can contribute mo... -
Integrated Evidence Planning That Connects Drug Development to Patient Needs 05.10.2026 33mHow do we generate evidence that supports regulatory approval, patient access, and better care? In this episode, I talk with Gorana Capkun from Merck Healthcare, where she leads the patient-focused and real-world evidence team. We explore how integrated evidence planning brings together clinical trials, real-world evidence, and patient perspectives across the product life cycle. Gorana explains why planning should begin early, how collaboration helps teams identify evidence gaps, and why statisticians play a critical role in turning broad requests into precise research questions. -
How to Make Statistics Click with Schools Outreach and Interactive Data Visualization 28.09.2026 27mHow can we make statistics meaningful to someone who does not work with it every day? I talk with Steve Mallett about his work with the PSI Schools team and the lessons it offers for training colleagues in pharma. We explore how hands-on activities, interactive data visualization, and a clear understanding of the audience can help people connect statistical concepts to patients and speak about results with greater confidence. -
Will AI Replace Statisticians? The Future of Statistics in Pharma 07.09.2026 24mWill artificial intelligence make statisticians obsolete—or make our expertise even more valuable? In this episode, I speak with independent statistical consultant Chris Harbron about how AI could reshape the role of statisticians in the pharmaceutical industry. Our conversation builds on Chris’s paper, Will the Pharmaceutical Industry Need Statisticians in an AI World? We explore what happens when AI generates protocols, statistical analysis plans, programs, and reports. We also discuss why producing a plausible document differs from making sound decisions about clinical development. Chris an... -
How to Build an Effective Patient-Reported Outcome Strategy for Clinical Trials 01.09.2026 20mHow can we build a patient-reported outcome strategy that captures the patient voice and strengthens clinical development? In this episode of The Effective Statistician Podcast, I speak with Julia Poritz, Senior Research Consultant on Cytel’s Evidence, Value, and Access team, about developing and implementing an effective patient-reported outcome (PRO) strategy for clinical trials. We discuss how PROs help us understand the effects of a disease and its treatment from the patient’s perspective—including symptoms, physical functioning, health perceptions, and overall quality of life. Julia expla... -
How the R Consortium Is Transforming Regulatory Submissions and AI in Clinical Trials 11.08.2026 18mIn this episode, I talk with Ning Leng, Ph.D., Director II, Data and AI Acceleration Group, Data & Statistical Sciences at AbbVie, about the growing role of the R Consortium in the pharmaceutical industry. Ning brings extensive experience in statistics, computational genomics, open-source technology, and the adoption of R across the pharmaceutical industry. Before joining AbbVie, she spent 10 years at Roche Genentech, where she helped drive the adoption of R, cloud technologies, Git, and Shiny. We discuss how the R Consortium creates a platform for statisticians, programmers, pharmaceutical co... -
Project Optimus and what you need to know about it 21.07.2026 25mCancer treatments have changed dramatically over the past decade, but have our dose-finding strategies kept pace? In this episode, I speak with Dr. Ayon Mukherjee, who leads statistical innovation in early oncology development at Eli Lilly. Together, we explore Project Optimus, the FDA initiative that is changing how we think about dose optimization in oncology. Instead of simply finding the highest dose patients can tolerate, Project Optimus encourages us to identify the dose that provides the best balance between efficacy, safety, pharmacokinetics, pharmacodynamics, and long-term tolerabilit... -
Unlocking Growth: The Power of Coaching and Mentoring for Statisticians 30.06.2026 35mIn this insightful interview, Emma May and Alun Bedding explore the nuances of coaching and mentoring, sharing personal stories, frameworks, and practical tips to enhance professional growth. Discover how these powerful tools can transform statisticians' careers and foster leadership development. -
Understanding and Mitigating Endpoint Bias in External Control Arms 09.06.2026 28mExternal control arms are becoming increasingly important in drug development, but creating valid comparisons requires more than matching patient populations. In this episode, I speak with Ben Ackerman, Director of Real-World Biostatistics at GSK, about one of the most overlooked challenges in external control arm studies: endpoint bias. We discuss why differences in how outcomes are measured can influence study results, what researchers should consider when designing studies, and how the field is evolving to address these challenges. If you work with real-world evidence, causal inference, or... -
The Future of Statistical Methodology in Drug Development 02.06.2026 31mThis episode features three leading statistical methodology experts discussing the role, impact, and future of methodology groups in the pharmaceutical industry. They explore organizational structures, skill sets, AI integration, and strategies to accelerate adoption of innovative methods. -
Rethinking Programming Validation and Traceability in Clinical Trials 26.05.2026 23mIn this episode of The Effective Statistician, I speak with Andrew (Andy) York about the evolving world of programming validation, traceability, and quality assurance in clinical trials. Andy has decades of experience in statistical programming, leadership roles across pharma and CROs, and now works with AI-driven solutions focused on improving validation and traceability. -
How Applied Improvisation Develops and Reinforces Interpersonal Skills 04.05.2026 33mIn this episode, Alun Bedding speaks with Richard Zink about how **applied improvisation** can help statisticians become more effective communicators and leaders. They explore how improv techniques—like “yes, and,” active listening, and embracing mistakes—build confidence, strengthen collaboration, and improve the way we explain complex ideas. This conversation shows that developing interpersonal skills doesn’t have to be theoretical or boring—it can be practical, interactive, and even fun. If you want to communicate your ideas more clearly, connect better with stakeholders, and grow beyond te... -
What does a clinical lead expect from a statistician? 27.04.2026 32mIn this episode, I speak with Anna Mosikian, a physician by training and Global Clinical Program Lead working at the intersection of clinical development and strategic marketing. Anna brings a powerful perspective on how clinical data translates into real-world value—bridging evidence generation, regulatory expectations, and commercial impact. We dive into what clinical leaders truly expect from statisticians and how statisticians can move from technical contributors to strategic partners. We explore what “good collaboration” really looks like in practice, why understanding the purpose of a st... -
Measuring Trust – A Key to Effective Leadership 21.04.2026 27mTrust is one of the most fundamental elements of effective leadership—and yet, most organizations don’t measure it properly. In this episode, I speak again with my good friend Alun Bedding about how we can move from talking about trust to actually quantifying and improving it. We explore why trust is essential for collaboration, leadership, and performance, and what happens when it’s missing. We also dive into practical tools like the Leadership Trust Index, how to interpret trust as a lead measure, and how organizations can systematically improve trust over time. If you want to become a more... -
Choosing and Interpreting PROs and COAs – A Guide for Clinical Trial Statisticians 14.04.2026 41mIn this episode, I sit down with Rachael Lawrance to dive into a topic that has become absolutely central to clinical research: patient-centered outcomes. When I first started as a statistician, I knew these measures existed—but I didn’t really understand how they were developed, analyzed, or used in decision-making. That has changed dramatically over the years. Today, patient-reported outcomes (PROs) and the broader framework of clinical outcome assessments (COAs) play a key role in regulatory approvals, payer decisions, and how we demonstrate treatment value. Rachael brings deep expertise fr... -
How Statisticians Can Build Trust and Lead with Emotional Intelligence 23.03.2026 39mIn this episode of The Effective Statistician, Alun Bedding speaks with Emma May about the skills that truly differentiate effective statisticians from great leaders. While technical expertise remains essential, success in today’s environment increasingly depends on the ability to build trust, communicate effectively, and lead with emotional intelligence. Drawing from their joint leadership workshops, Alun and Emma explore how statisticians can develop these capabilities and apply them in real-world settings. They discuss practical approaches to creating psychological safety, shifting from a “...
Popular in
The podcast also appears in the podcast charts of these countries.